Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Hartaj Singh's Stock Ratings
Oppenheimer Analyst
Hartaj Singh is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/17/2025
Updated: Dec 17, 2025
Overall Average Return
-8.36%
Smart Score
Overall Average Return Percentile
20th
Number of Ratings
148
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 07/29/2025 | SRPT | Buy Now | Sarepta Therapeutics | $22.28 | 66.07% | $30 → $37 | Upgrade | Perform → Outperform | Get Alert | |
| 07/18/2025 | SRPT | Buy Now | Sarepta Therapeutics | $22.28 | 84.02% | $45 → $41 | Maintains | Outperform | Get Alert | |
| 06/20/2025 | SRPT | Buy Now | Sarepta Therapeutics | $22.28 | 101.97% | $123 → $45 | Maintains | Outperform | Get Alert | |
| 05/07/2025 | SRPT | Buy Now | Sarepta Therapeutics | $22.28 | 452.06% | $184 → $123 | Maintains | Outperform | Get Alert | |
| 04/29/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $746.36 | 20.59% | $925 → $900 | Maintains | Outperform | Get Alert | |
| 04/25/2025 | GILD | Buy Now | Gilead Sciences | $118.78 | 5.24% | $132 → $125 | Maintains | Outperform | Get Alert | |
| 04/03/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $746.36 | 23.93% | $950 → $925 | Maintains | Outperform | Get Alert | |
| 03/04/2025 | GILD | Buy Now | Gilead Sciences | $118.78 | 11.13% | $115 → $132 | Maintains | Outperform | Get Alert | |
| 01/10/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $746.36 | 27.28% | $1000 → $950 | Maintains | Outperform | Get Alert | |
| 12/19/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 12/11/2024 | SPRB | Buy Now | Spruce Biosciences | $78.00 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 11/14/2024 | ATXS | Buy Now | Astria Therapeutics | $12.87 | 117.56% | $26 → $28 | Maintains | Outperform | Get Alert | |
| 11/07/2024 | GILD | Buy Now | Gilead Sciences | $118.78 | -11.6% | $95 → $105 | Maintains | Outperform | Get Alert | |
| 11/06/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $746.36 | 33.98% | $1150 → $1000 | Maintains | Outperform | Get Alert | |
| 10/31/2024 | UTHR | Buy Now | United Therapeutics | $490.00 | 22.45% | $575 → $600 | Maintains | Outperform | Get Alert | |
| 10/30/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | 18.69% | $550 → $540 | Maintains | Outperform | Get Alert | |
| 09/13/2024 | MRNA | Buy Now | Moderna | $29.76 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 08/28/2024 | UTHR | Buy Now | United Therapeutics | $490.00 | 17.35% | $400 → $575 | Maintains | Outperform | Get Alert | |
| 08/13/2024 | ATXS | Buy Now | Astria Therapeutics | $12.87 | 102.02% | $25 → $26 | Maintains | Outperform | Get Alert | |
| 08/05/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | 20.89% | $500 → $550 | Maintains | Outperform | Get Alert | |
| 06/13/2024 | SPRB | Buy Now | Spruce Biosciences | $78.00 | -96.15% | $4 → $3 | Maintains | Outperform | Get Alert | |
| 06/12/2024 | CLLS | Buy Now | Cellectis | $4.26 | 134.74% | $11 → $10 | Maintains | Outperform | Get Alert | |
| 06/12/2024 | MRNA | Buy Now | Moderna | $29.76 | 501.48% | $163 → $179 | Maintains | Outperform | Get Alert | |
| 05/30/2024 | BMEA | Buy Now | Biomea Fusion | $1.38 | 4247.83% | $70 → $60 | Maintains | Outperform | Get Alert | |
| 05/23/2024 | VIRX | Buy Now | Viracta Therapeutics | $0.01 | 112374.44% | $13 → $11 | Maintains | Outperform | Get Alert | |
| 05/21/2024 | ATXS | Buy Now | Astria Therapeutics | $12.87 | 94.25% | $29 → $25 | Maintains | Outperform | Get Alert | |
| 05/14/2024 | SRPT | Buy Now | Sarepta Therapeutics | $22.28 | 707.9% | → $180 | Upgrade | Perform → Outperform | Get Alert | |
| 05/03/2024 | MRNA | Buy Now | Moderna | $29.76 | 447.72% | $142 → $163 | Maintains | Outperform | Get Alert | |
| 05/02/2024 | UTHR | Buy Now | United Therapeutics | $490.00 | -18.37% | $375 → $400 | Maintains | Outperform | Get Alert | |
| 04/23/2024 | GANX | Buy Now | Gain Therapeutics | $3.89 | 131.09% | → $9 | Maintains | Outperform | Get Alert | |
| 04/19/2024 | GILD | Buy Now | Gilead Sciences | $118.78 | -11.6% | $105 → $105 | Maintains | Outperform | Get Alert | |
| 04/17/2024 | VIRX | Buy Now | Viracta Therapeutics | $0.01 | 132824.34% | → $13 | Maintains | Outperform | Get Alert | |
| 04/15/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | 9.9% | → $500 | Maintains | Outperform | Get Alert | |
| 04/03/2024 | BMEA | Buy Now | Biomea Fusion | $1.38 | 4972.46% | → $70 | Maintains | Outperform | Get Alert | |
| 03/26/2024 | ATXS | Buy Now | Astria Therapeutics | $12.87 | 125.33% | $25 → $29 | Maintains | Outperform | Get Alert | |
| 03/26/2024 | HARP | Buy Now | Harpoon Therapeutics | — | — | — | Maintains | Outperform | Get Alert | |
| 03/08/2024 | INO | Buy Now | Inovio Pharmaceuticals | $2.33 | 1616.66% | $40 → $40 | Maintains | Outperform | Get Alert | |
| 02/12/2024 | GILD | Buy Now | Gilead Sciences | $118.78 | -11.6% | $115 → $105 | Maintains | Outperform | Get Alert | |
| 01/25/2024 | INO | Buy Now | Inovio Pharmaceuticals | $2.33 | 71.67% | → $4 | Upgrade | Perform → Outperform | Get Alert | |
| 01/05/2024 | TRDA | Buy Now | Entrada Therapeutics | $11.37 | 93.49% | → $22 | Initiates | → Outperform | Get Alert | |
| 01/05/2024 | HARP | Buy Now | Harpoon Therapeutics | — | — | → $23 | Initiates | → Outperform | Get Alert | |
| 01/02/2024 | MRNA | Buy Now | Moderna | $29.76 | 377.15% | → $142 | Upgrade | Perform → Outperform | Get Alert | |
| 11/15/2023 | ATXS | Buy Now | Astria Therapeutics | $12.87 | 94.25% | $30 → $25 | Maintains | Outperform | Get Alert | |
| 10/02/2023 | ICVX | Buy Now | Icosavax | — | — | → $25 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/13/2023 | OPT | Buy Now | Opthea | — | — | $31 → $16 | Maintains | Outperform | Get Alert | |
| 08/21/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $746.36 | 40.68% | $950 → $1050 | Maintains | Outperform | Get Alert | |
| 08/18/2023 | SPRB | Buy Now | Spruce Biosciences | $78.00 | -91.03% | $8 → $7 | Maintains | Outperform | Get Alert | |
| 08/08/2023 | CLLS | Buy Now | Cellectis | $4.26 | 158.22% | → $11 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/04/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $746.36 | 27.28% | $900 → $950 | Maintains | Outperform | Get Alert | |
| 08/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | -9.88% | → $410 | Reiterates | Outperform → Outperform | Get Alert | |
| 07/11/2023 | ELOX | Buy Now | Eloxx Pharmaceuticals | $0.00 | 54999900% | $50 → $55 | Maintains | Outperform | Get Alert | |
| 07/05/2023 | LIFE | Buy Now | aTyr Pharma | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 06/12/2023 | GANX | Buy Now | Gain Therapeutics | $3.89 | 156.77% | → $10 | Reiterates | Outperform → Outperform | Get Alert | |
| 06/08/2023 | ATXS | Buy Now | Astria Therapeutics | $12.87 | 133.1% | → $30 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/26/2023 | SRPT | Buy Now | Sarepta Therapeutics | $22.28 | 707.9% | → $180 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/23/2023 | SPRB | Buy Now | Spruce Biosciences | $78.00 | -89.74% | → $8 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | -9.88% | $350 → $410 | Maintains | Outperform | Get Alert | |
| 04/25/2023 | ICVX | Buy Now | Icosavax | — | — | → $27 | Reiterates | → Outperform | Get Alert | |
| 04/11/2023 | BMEA | Buy Now | Biomea Fusion | $1.38 | 3305.8% | → $47 | Reiterates | → Outperform | Get Alert | |
| 04/06/2023 | ELOX | Buy Now | Eloxx Pharmaceuticals | $0.00 | 49999900% | → $50 | Reiterates | → Outperform | Get Alert | |
| 04/04/2023 | ONCT | Buy Now | Oncternal Therapeutics | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 03/29/2023 | BMEA | Buy Now | Biomea Fusion | $1.38 | 3305.8% | $25 → $47 | Maintains | Outperform | Get Alert | |
| 03/27/2023 | VIRX | Buy Now | Viracta Therapeutics | $0.01 | 163499.18% | $14 → $16 | Maintains | Outperform | Get Alert | |
| 03/22/2023 | ONCT | Buy Now | Oncternal Therapeutics | — | — | $14 → $9 | Maintains | Outperform | Get Alert | |
| 03/13/2023 | OPT | Buy Now | Opthea | — | — | $36 → $31 | Maintains | Outperform | Get Alert | |
| 03/13/2023 | CLLS | Buy Now | Cellectis | $4.26 | 205.16% | $16 → $13 | Maintains | Outperform | Get Alert | |
| 03/09/2023 | SRPT | Buy Now | Sarepta Therapeutics | $22.28 | 573.25% | $180 → $150 | Maintains | Outperform | Get Alert | |
| 03/01/2023 | SRPT | Buy Now | Sarepta Therapeutics | $22.28 | 707.9% | $150 → $180 | Maintains | Outperform | Get Alert | |
| 01/04/2023 | ICVX | Buy Now | Icosavax | — | — | → $27 | Initiates | → Outperform | Get Alert | |
| 11/25/2022 | GANX | Buy Now | Gain Therapeutics | $3.89 | 156.77% | $30 → $10 | Maintains | Outperform | Get Alert | |
| 11/17/2022 | SPRB | Buy Now | Spruce Biosciences | $78.00 | -89.74% | $13 → $8 | Maintains | Outperform | Get Alert | |
| 11/11/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | -23.07% | → $350 | Maintains | Outperform | Get Alert | |
| 11/03/2022 | UTHR | Buy Now | United Therapeutics | $490.00 | -23.47% | $325 → $375 | Maintains | Outperform | Get Alert | |
| 10/21/2022 | NBSE | Buy Now | NeuBase Therapeutics | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 05/11/2022 | INO | Buy Now | Inovio Pharmaceuticals | $2.33 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 04/04/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | -23.07% | $305 → $350 | Maintains | Outperform | Get Alert | |
| 02/08/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $746.36 | 3.84% | $825 → $775 | Maintains | Outperform | Get Alert | |
| 12/17/2021 | SPRB | Buy Now | Spruce Biosciences | $78.00 | -80.77% | → $15 | Initiates | → Outperform | Get Alert | |
| 12/17/2021 | BMEA | Buy Now | Biomea Fusion | $1.38 | 1494.2% | → $22 | Initiates | → Outperform | Get Alert | |
| 12/17/2021 | ELOX | Buy Now | Eloxx Pharmaceuticals | $0.00 | 3999900% | → $4 | Initiates | → Outperform | Get Alert | |
| 12/09/2021 | SRPT | Buy Now | Sarepta Therapeutics | $22.28 | 461.04% | → $125 | Upgrade | Perform → Outperform | Get Alert | |
| 09/14/2021 | LIFE | Buy Now | aTyr Pharma | — | — | $14 → $20 | Maintains | Outperform | Get Alert | |
| 08/06/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $746.36 | 10.54% | $725 → $825 | Maintains | Outperform | Get Alert | |
| 08/06/2021 | MRNA | Buy Now | Moderna | $29.76 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 04/16/2021 | FSTX | Buy Now | F-star Therapeutics | — | — | → $30 | Initiates | → Outperform | Get Alert | |
| 04/12/2021 | GANX | Buy Now | Gain Therapeutics | $3.89 | 670.3% | → $30 | Initiates | → Outperform | Get Alert | |
| 04/07/2021 | ONCT | Buy Now | Oncternal Therapeutics | — | — | → $14 | Initiates | → Outperform | Get Alert | |
| 03/24/2021 | LIFE | Buy Now | aTyr Pharma | — | — | $12 → $14 | Maintains | Outperform | Get Alert | |
| 03/11/2021 | CATB | Buy Now | Catabasis Pharmaceuticals | — | — | → $5 | Upgrade | Perform → Outperform | Get Alert | |
| 02/23/2021 | SNSS | Buy Now | Sunesis Pharmaceuticals | — | — | → $12 | Upgrade | Perform → Outperform | Get Alert | |
| 02/16/2021 | UTHR | Buy Now | United Therapeutics | $490.00 | -43.88% | $200 → $275 | Maintains | Outperform | Get Alert | |
| 02/12/2021 | INO | Buy Now | Inovio Pharmaceuticals | $2.33 | 1402.08% | → $35 | Initiates | → Outperform | Get Alert | |
| 02/01/2021 | MRNA | Buy Now | Moderna | $29.76 | 592.2% | $178 → $206 | Maintains | Outperform | Get Alert | |
| 11/11/2020 | OPT | Buy Now | Opthea | — | — | → $36 | Initiates | → Outperform | Get Alert | |
| 10/27/2020 | CATB | Buy Now | Catabasis Pharmaceuticals | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 09/10/2020 | GILD | Buy Now | Gilead Sciences | $118.78 | -11.6% | $90 → $105 | Maintains | Outperform | Get Alert | |
| 07/30/2020 | UTHR | Buy Now | United Therapeutics | $490.00 | -66.33% | $155 → $165 | Maintains | Outperform | Get Alert | |
| 07/16/2020 | CLSN | Buy Now | Celsion | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 07/01/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $746.36 | -9.56% | $625 → $675 | Maintains | Outperform | Get Alert | |
| 06/24/2020 | SNSS | Buy Now | Sunesis Pharmaceuticals | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 05/01/2020 | GILD | Buy Now | Gilead Sciences | $118.78 | -24.23% | $80 → $90 | Maintains | Outperform | Get Alert | |
| 04/30/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | -32.96% | $265 → $305 | Maintains | Outperform | Get Alert | |
| 04/15/2020 | MRNA | Buy Now | Moderna | $29.76 | 44.49% | $31 → $43 | Maintains | Outperform | Get Alert | |
| 04/01/2020 | NBSE | Buy Now | NeuBase Therapeutics | — | — | $14 → $17 | Maintains | Outperform | Get Alert | |
| 03/17/2020 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 03/11/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $746.36 | -29.66% | $450 → $525 | Maintains | Outperform | Get Alert | |
| 03/02/2020 | LIFE | Buy Now | aTyr Pharma | — | — | → $8 | Initiates | → Outperform | Get Alert | |
| 01/08/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | -41.75% | $230 → $265 | Maintains | Outperform | Get Alert | |
| 11/21/2019 | NBSE | Buy Now | NeuBase Therapeutics | — | — | → $14 | Initiates | → Outperform | Get Alert | |
| 10/25/2019 | GILD | Buy Now | Gilead Sciences | $118.78 | -32.65% | $85 → $80 | Maintains | Outperform | Get Alert | |
| 03/07/2019 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | -49.45% | $200 → $230 | Maintains | Outperform | Get Alert | |
| 01/03/2019 | GILD | Buy Now | Gilead Sciences | $118.78 | — | — | Upgrade | Perform → Outperform | Get Alert | |
| 01/02/2019 | MRNA | Buy Now | Moderna | $29.76 | -9.27% | → $27 | Initiates | → Outperform | Get Alert | |
| 11/01/2018 | SLS | Buy Now | SELLAS Life Sciences Gr | $2.25 | 477.78% | → $13 | Initiates | → Outperform | Get Alert | |
| 06/27/2018 | REGN | Buy Now | Regeneron Pharmaceuticals | $746.36 | — | — | Upgrade | Perform → Outperform | Get Alert | |
| 06/12/2018 | CLLS | Buy Now | Cellectis | $4.26 | 932.86% | $40 → $44 | Maintains | Outperform | Get Alert | |
| 06/12/2018 | ARQL | Buy Now | Arqule | — | — | → $7 | Initiates | → Outperform | Get Alert | |
| 05/04/2018 | SRPT | Buy Now | Sarepta Therapeutics | $22.28 | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 01/26/2018 | SMMT | Buy Now | Summit Therapeutics | $17.18 | 74.62% | $24 → $30 | Maintains | Outperform | Get Alert | |
| 11/21/2017 | SNSS | Buy Now | Sunesis Pharmaceuticals | — | — | — | Initiates | → Outperform | Get Alert | |
| 11/21/2017 | CLSN | Buy Now | Celsion | — | — | → $9 | Initiates | → Outperform | Get Alert | |
| 10/05/2017 | GILD | Buy Now | Gilead Sciences | $118.78 | — | — | Initiates | → Perform | Get Alert | |
| 07/28/2017 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | — | Upgrade | Perform → Outperform | Get Alert | |
| 06/02/2017 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | — | — | Upgrade | Perform → Outperform | Get Alert | |
| 12/15/2016 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | — | Initiates | → Perform | Get Alert | |
| 12/15/2016 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | — | — | Initiates | → Perform | Get Alert | |
| 12/14/2016 | UTHR | Buy Now | United Therapeutics | $490.00 | — | — | Initiates | → Outperform | Get Alert | |
| 05/02/2016 | SRPT | Buy Now | Sarepta Therapeutics | $22.28 | — | — | Upgrade | Perform → Outperform | Get Alert | |
| 04/26/2016 | SRPT | Buy Now | Sarepta Therapeutics | $22.28 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 04/06/2016 | SRPT | Buy Now | Sarepta Therapeutics | $22.28 | 169.3% | $45 → $60 | Maintains | Outperform | Get Alert | |
| 02/11/2016 | GILD | Buy Now | Gilead Sciences | $118.78 | 1.03% | → $120 | Initiates | → Outperform | Get Alert | |
| 02/11/2016 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | — | — | Assumes | → Perform | Get Alert | |
| 02/03/2016 | GILD | Buy Now | Gilead Sciences | $118.78 | 1.03% | $124 → $120 | Maintains | Outperform | Get Alert | |
| 10/20/2015 | GILD | Buy Now | Gilead Sciences | $118.78 | 4.39% | $120 → $124 | Maintains | Outperform | Get Alert | |
| 07/20/2015 | CATB | Buy Now | Catabasis Pharmaceuticals | — | — | → $28 | Initiates | → Outperform | Get Alert | |
| 05/22/2015 | CLLS | Buy Now | Cellectis | $4.26 | 1425.82% | → $65 | Initiates | → Outperform | Get Alert | |
| 04/27/2015 | GILD | Buy Now | Gilead Sciences | $118.78 | — | — | Assumes | → Outperform | Get Alert | |
| 04/27/2015 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | — | — | Assumes | → Perform | Get Alert | |
| 04/27/2015 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | — | Assumes | → Outperform | Get Alert | |
| 07/08/2014 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | — | — | Initiates | → Market Perform | Get Alert | |
| 02/13/2014 | REGN | Buy Now | Regeneron Pharmaceuticals | $746.36 | -56.46% | $31 → $325 | Downgrade | Outperform → Market Perform | Get Alert | |
| 09/30/2013 | REGN | Buy Now | Regeneron Pharmaceuticals | $746.36 | -58.47% | $300 → $310 | Maintains | Outperform | Get Alert | |
| 08/21/2013 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | -76.92% | → $105 | Initiates | → Outperform | Get Alert | |
| 08/21/2013 | REGN | Buy Now | Regeneron Pharmaceuticals | $746.36 | -59.8% | → $300 | Initiates | → Outperform | Get Alert | |
| 08/21/2013 | REGN | Buy Now | Regeneron Pharmaceuticals | $746.36 | -59.8% | → $300 | Initiates | → Outperform | Get Alert | |
| 03/14/2013 | GILD | Buy Now | Gilead Sciences | $118.78 | -57.91% | $45 → $50 | Maintains | Outperform | Get Alert | |
| 02/14/2013 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | $134 → $115 | Maintains | Outperform | Get Alert | |
| 03/29/2012 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | $89 → $100 | Maintains | Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved